Rituxan (rituximab) - Roche
cyclophosphamide - Generic mfg.
Outcomes of intensive care patients with acute small-vessel vasculitis: a 23-year single-centre experience. (PubMed, Rheumatology (Oxford)) - Sep 24, 2026 - "This single-centre study reports ICU outcomes for patients with fulminant SVV over 23 years. 30 and 90-day ICU mortality were comparable with other reported values. Improvement in mortality was associated with changes in vasculitis treatment protocols." 
Journal • ANCA Vasculitis • Chronic Kidney Disease • Critical care • Nephrology • Renal Disease • Vasculitis
http://www.ncbi.nlm.nih.gov/pubmed/42773518
 
Arden Dierker Viik; David Jayne; Dominic McGovern; Iftach Sagy; James Varley; Lisa Willcocks; Michael Chen-Xu; Rachel Jones; Rona Smith; Seerapani Gopaluni; Yiwang Xu
 
Sep 24, 2026
 
Prev Next